These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 11242605

  • 1. How long can insulin therapy be avoided in the patient with type 2 diabetes mellitus by use of a combination of metformin and a sulfonylurea?
    Bell DS, Ovalle F.
    Endocr Pract; 2000; 6(4):293-5. PubMed ID: 11242605
    [Abstract] [Full Text] [Related]

  • 2. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL.
    Ann Intern Med; 2001 May 01; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [Abstract] [Full Text] [Related]

  • 3. Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.
    Hershon KS, Hershon PM.
    Endocr Pract; 2000 May 01; 6(1):20-5. PubMed ID: 11419922
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long-term efficacy of triple oral therapy for type 2 diabetes mellitus.
    Bell DS, Ovalle F.
    Endocr Pract; 2002 May 01; 8(4):271-5. PubMed ID: 12173913
    [Abstract] [Full Text] [Related]

  • 6. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF, Traylor L, Schwartz SL.
    Endocr Pract; 2010 May 01; 16(4):588-99. PubMed ID: 20350924
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL, Stewart J, Issa M, Lake B, Melis R.
    Clin Ther; 2005 Oct 01; 27(10):1535-47. PubMed ID: 16330290
    [Abstract] [Full Text] [Related]

  • 9. Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.
    Riedel AA, Heien H, Wogen J, Plauschinat CA.
    Am J Manag Care; 2007 Aug 01; 13(8):457-63. PubMed ID: 17685826
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Concomitant oral antihyperglycemic agent use and associated treatment outcomes after initiation of insulin therapy.
    Herman WH, Buse JB, Arakaki RF, Dungan KM, Jiang HH, Jacobson JG, Fahrbach JL.
    Endocr Pract; 2011 Aug 01; 17(4):563-7. PubMed ID: 21550959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 2-year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with type 2 diabetes.
    Seufert J, Urquhart R.
    Diabetes Res Clin Pract; 2008 Mar 01; 79(3):453-60. PubMed ID: 18160120
    [Abstract] [Full Text] [Related]

  • 14. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC, Cull CA, Frighi V, Holman RR.
    JAMA; 1999 Jun 02; 281(21):2005-12. PubMed ID: 10359389
    [Abstract] [Full Text] [Related]

  • 15. Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control.
    Gavin LA, Barth J, Arnold D, Shaw R.
    Endocr Pract; 2000 Jun 02; 6(4):305-10. PubMed ID: 11242607
    [Abstract] [Full Text] [Related]

  • 16. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
    Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.
    Diabetes Care; 2006 Mar 02; 29(3):554-9. PubMed ID: 16505505
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with pioglitazone plus metformin or sulfonylurea in patients with Type 2 diabetes: influence of prior antidiabetic drug regimen.
    Rendell MS, Glazer NB, Ye Z.
    J Diabetes Complications; 2003 Mar 02; 17(4):211-7. PubMed ID: 12810245
    [Abstract] [Full Text] [Related]

  • 18. Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial.
    Aljabri K, Kozak SE, Thompson DM.
    Am J Med; 2004 Feb 15; 116(4):230-5. PubMed ID: 14969650
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.